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mRNA degradationThe Ccr4-Not complex is a conserved multi-subunit complex in eukaryotes that carries 2 enzymatic activities:
ubiquitinationmediated by theNot4 RING E3 ligase and deadenylationmediated by the Ccr4 and Caf1 orthologs.
This complex has been implicated in all aspects of themRNA life cycle, from synthesis ofmRNAs in the nucleus to
their degradation in the cytoplasm. More recently the complex has also been implicated in many aspects of the
life cycle of proteins, from quality control during synthesis of peptides, to assembly of protein complexes and
protein degradation. Consistently, the Ccr4-Not complex is found both in the nucleus, where it is connected to
transcribing ORFs, and in the cytoplasm, where it was revealed to be both associatedwith translating ribosomes
and in RNA processing bodies. This functional and physical presence of the Ccr4-Not complex at all stages of gene
expression raises the question of its fundamental role. This reviewwill summarize recent evidence designing the
Not3/5 module of the Ccr4-Not complex as a functional module involved in coordination of the regulation of
gene expression between the nucleus and the cytoplasm.
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Eukaryotic cells must continuously evolve to adapt to their environ-
ment. For unicellular organisms, changes in the environment aremostly
related to nutrient levels, and the extent of different stresses, including
temperature changes, heavy metals, oxidative stress and many more.
But the role of the environment ismuchmore complex formulticellular
organisms. Indeed, a cell must additionally be able to integrate signals
originating from the other cells of the organism, even from cells at dis-
tant sites. These signals arriving at the cell surface are of diverse types
that include proteins, lipids and chemicals, and they will interact with
the cell via receptors or transporters at the cell surface. Consequently,
signaling cascades will be activated leading to a multitude of different
modiﬁcations and adaptations within cells. Each signal leads to its spe-
ciﬁc characteristic cascade of events via its speciﬁc combination of sec-
ond messengers. On one hand immediate responses are induced, such
as fusion of secretory granules with the cell surface [1]. On the other
hand, expression of speciﬁc genes is altered, either transiently to respond
to a transient modiﬁcation of the environment, or longer-lastingly to
modify gene expression programs.Modiﬁcation of gene expression in re-
sponse to a signal involves not only activation of new genes, but also
switching off the genetic program that was in place before. This shut
down involves repression of the transcription of genes, and degradation
of proteins and mRNAs that are no longer needed [2–4].
Transcription factors that coordinate activation of speciﬁc families of
genes have been characterized and the regulation of their activity in re-
sponse to signaling pathways is in many cases well deﬁned [5]. Degra-
dation of mRNAs and proteins has also been studied in response to
signaling cascades [6,7]. However how the transcription responses are
connected with the cytoplasmic events is much less understood. One
recent study revealed that mRNA synthesis and degradation mutually
feedback onto each other [8]. Another uncovered opposite evolutionary
changes in transcription and mRNA degradation rates that were mech-
anistically coupled and generated by the same individual mutations [9].
A large fraction of these mutations mapped to the genes encoding the
Rpb4/7 sub-complex of RNA polymerase II or the genes encoding the
Ccr4, Caf1 andNot5 subunits of the Ccr4-Not complex [9]. This is consis-
tentwith studies implicating Rbp4/7 as well as the Ccr4-Not complex in
both the transcription and mRNA degradation processes [10–13].
The Ccr4-Not complex is a conserved multi-subunit complex that
regulates gene expression at multiple levels (for reviews see [14–16]).
Besides its role in mRNA synthesis and degradation it has also been
connected to protein quality control [17–20]. It is the ideal candidate
for coordination of gene expression at all levels in cells, in response to
modiﬁcation of the environment. Many studies ﬁrst in yeast, and more
recently in higher eukaryotes, provide evidence for such a fundamental
role of the Ccr4-Not complex in eukaryotic gene expression. In this re-
view we will go over some of the recent studies that highlight such a
role, and in particular shed light on a new functional module composed
of Not3/5 and Not2.
2. Description of the Ccr4-Not complex
2.1. Composition
The Ccr4-Not complex is evolutionarily conserved from yeast to
human [21–25]. In Saccharomyces cerevisiae the core of the Ccr4-Not
complex has a size of about 1 MDa and comprises 9 proteins (5
Not proteins, 3 Caf proteins and 1 Ccr4) [26,27]. The Not proteins
(Not1, Not2, Not3, Not4 and Not5) obtained their name (Negative
On TATA-less) from a selection suggesting that the NOT genes are
important for repressing promoters lacking a canonical TATA box [28].
CCR4 (Carbon Catabolite Repression) was identiﬁed as a gene that pos-
itively regulates glucose-repressible enzymes [29]. The Caf proteins
(Caf1, Caf40 and Caf130) derived their name from interaction with
Ccr4 (Ccr4 associated factor) [30,31]. Other proteins, such as Caf4,Caf16, Dhh1, Btt1 and several other less well-characterized proteins
[32–35], associate with the core of the Ccr4-Not core in large com-
plexes with the size of about 2 MDa (for review see [15]). In
human cells there are two genes orthologous to yeast CAF1, CNOT7
and CNOT8 and 2 genes orthologous to CCR4, CNOT6 and CNOT6L
[21,22] and for review see [11]. In contrast, there is only one gene,
CNOT3, that is the ortholog of yeast NOT3 and NOT5, which have
probably originated from a gene duplication event. They encode
proteins with very similar N-termini, but have distinct C-termini
(Fig. 1). Not5 has retained most of the essential functions and is
quite critically important for yeast vegetative growth while dele-
tion of Not3 has only very mild phenotypes [36]. The N-terminal
domain of Not5 that is homologous to the N-terminal domain of
Not3 is essential for growth at high temperature in the absence
of Not3 [36]. But the critical importance of Not5 for vegetative
growth really maps to its C-terminus (Fig. 1).
2.2. Structure
The only structural data about the Ccr4-Not complex is known
from baker's yeast. Not1 is the largest protein of the complex and
is the major scaffolding protein to which the other Ccr4-Not subunits
bind [26]. According to the electronmicroscopy data, the Ccr4-Not com-
plex has an L-shape with two arms of 180 Å and 190 Å and a hinge do-
main in themiddle [37]. The shorter arm is thought to bemainly formed
by the Not proteins, whereas the longer, thinner arm, contains Caf40
and Caf130. Caf1 binds to the middle part of Not1 and brings Ccr4 to
the scaffold [38,39]. Thus Ccr4 is positioned at a strategic place in
the hinge-domain. Since biochemical and genetic data indicate that
the Not-subunits interact with the C-terminus of Not1 it is likely
that shorter arm corresponds to the C-terminus of Not1, and the lon-
ger arm to the N-terminus. The two-arm shape resolved by electron
microscopy is very consistent with previous biochemical, molecular
and genetic data (summarized in [11]). However, the complex is in
fact heterogeneous, and an enrichment for L-shaped particles containing
all Ccr4-Not subunits could be obtained only after chemical cross-linking
of the puriﬁed complex [37].
2.3. Function
All the evidence points to the existence of different modules built
on the Not1 scaffold, which perform different functions and contrib-
ute to regulate gene expression at different levels (Fig. 2). The exis-
tence of 2 enzymatic activities within the Ccr4-Not complex has
clearly designated 2 functional modules (for review see [14]).
2.3.1. Ccr4–Caf1 module
Caf1 and Ccr4 comprise the major eukaryotic deadenylase [40]. They
perform the rate limiting deadenylation step in mRNA degradation.
Ccr4 is a 3′exonuclease that has a DNA I-like EEP (endonuclease–exonu-
clease–phosphatase) domain [41,42]. Caf1 also has 3′exonuclease activity
and contains an RNaseD/DEDD domain [43–45]. In S. cerevisiae Caf1 har-
bors a mutation in the active site [44] and does not contribute to the en-
zymatic activity, however already in Schizosaccharomyces pombe and
further up in evolution, Caf1 contains the conserved catalytical residues
[46] and is active.
2.3.2. Not4 module
Not4 is a C4C4 RING E3 ligase, bearing in its RING two clusters of 4
Cys residues that coordinate two ions of Zn [47]. It not only directly
ubiquitinates a variety of different substrates [17,19,20,48–50], but
also exerts functions that require its association into the Ccr4-Not
complex and its RING domain, but not its E3 ligase activity [18]. The
role of Not4 appears to be regulatory. At the ribosome it plays a role
in co-translational quality control, probably of both mRNA and protein
(for review see Collart 2012, in press). Its function as an E3 ligase is
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Fig. 1. Schematic representation of known sequences of yeast Not5, yeast Not3 and human CNot3. The numbers correspond to the domain entries in the InterPro database (http://
www.ebi.ac.uk/interpro/) and the HMMPham database (http://pfam.sanger.ac.uk/) respectively.
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transcriptional responses, since it ubiquitinates and destabilizes
stress-inducible transcription factors [49,50] or components that impact
on the state of the chromatin [48]. Not4 also regulates DNA-binding of
transcription factors [51] and interaction of transcription factors with
co-activators [52]. Finally, Not4 is important for the assembly of a large
multi-subunit complex, the proteasome, and for this function it needs
its RING and Ccr4-Not interaction domains, but it does not require its
E3 ligase activity [18].2.3.3. Not2–3/5 module
A third module is composed of Not3/5 and Not2. Many genetic ex-
periments in yeast have shown that these proteins function together
(for review see [15]), and we have data showing that recombinant
Not2 and Not5 associate in a stable complex (Bukach et al., in prepa-
ration). The role of this module however, has been difﬁcult to assess.
In yeast, besides Not1 that is essential for viability, these 2 proteins
are the most important for vegetative growth [14]. Many experiments
have suggested that this module is closely connected to the transcrip-
tion machinery [52–62] and to nuclear functions such as nuclear RNA
surveillance and mRNA export [63–65]. Nevertheless, Not5 like otherCCR4 
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NOT3 
CAF40 
CAF130 
NOT4 
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Fig. 2. Scheme of the Ccr4-Not complex indicating functional modules in different
colors. Blue is for the Not2–3/5 module that associates with transcribing ORFs and/or
mRNAs for Ccr4-Not complex recruitment; pink is for the Not4 module involved in
protein quality control; yellow is for the Caf1–Ccr4 module involved in mRNA degrada-
tion. The Not1 scaffold is indicated in green. The Caf40 and Caf130 proteins whose
exact function is not yet deﬁned are in gray.subunits of the Ccr4-Not complex is also present at translating ribosomes
[19]. Interestingobservations about thismodule of the Ccr4-Not complex
have emerged from studies in higher eukaryotes [66–71]. They link this
module both to coordination of transcriptional regulation and mRNA
degradation (see below), while work in our group suggests the impor-
tance of this module for assembly of cellular complexes such as the
proteasome (see below).
2.4. The Ccr4-Not complex: a platform that coordinates functions of its
modules
The association of all Ccr4-Not subunits within a complex is essential
for cell viability, but it remains unclear whether the different subunits
work onlywithin the context of a complex, orwhether the different func-
tional modules also work outside of the complex. The observation that
human CNot4 is not constitutively associated with the complex suggests
that the modules may perform part of their function outside of the com-
plex. However integration of the modules into the complex is at some
point during their functional cycle essential, as will be outlined below.
2.4.1. Role in mRNA degradation
The role of Ccr4 and Caf1 in mRNA deadenylation has been exten-
sively described in many different reviews [72–75] and will not be cov-
ered here, except to remind the reader that mRNA deadenylation is the
initial rate-limiting step in the major pathway of mRNA degradation. It
is generally thought to be initiated by recruitment of the deadenylase to
mRNA 3′UTRs via speciﬁc RNA binding proteins. Within the Ccr4-Not
complex, only Ccr4 and Caf1 clearly contribute to the deadenylation
process, but various different other subunits of the complex have been
described as important for recruitment of the deadenylase to speciﬁc
mRNAs (reviewed in [14]). Moreover, while in vitro Caf1 and Ccr4
are active deadenylases in the absence of Not1 [44,76,77], in vivo
deadenylation requires Not1 [38,78]. These observations suggest
that integration of Ccr4 and Caf1 within the Ccr4-Not complex may
allow speciﬁc targeting and regulation of deadenylation. Hence, in
cells deadenylation appears to be performed by Ccr4–Caf1, but in
the context of the Ccr4-Not complex. Consistently formation of process-
ing bodies, which contain factors required for translation repression,
decapping and mRNA degradation (including Ccr4 and Caf1), requires
deadenylation [79], and CNot1 aswell as the deadenylase subunits [78].
2.4.2. Role in nuclear transcription
The contribution of the different subunits of the Ccr4-Not complex to
transcription has not been well delimited (for reviews see [13,14,16]).
Mostly the Not subunits of the complex have been connected to this
746 M.A. Collart et al. / Cellular Signalling 25 (2013) 743–751function as mentioned above. The connections have been multiple. Not4
regulates stability of transcription factors or chromatin modifying en-
zymes [48–50]. Not4 also regulates interaction of transcription factors
with co-factors [52] or DNA [51]. Ccr4-Not subunits cross-link to tran-
scribing ORFs. This has been shown speciﬁcally not only for yeast Not2,
Not5, Ccr4 and Caf1 [57,80] but also genome-wide to some extent for
all subunits [81], though clearly Not2 and Not3 cross-link to the largest
numbers of promoters. The human orthologs of Not1, Not2 and Caf1
also cross-link to promoters [82]. Not5 interacts with the general tran-
scription factor TFIID [56–58,61] and Not1, Not2 and Not5 interact with
the SAGA histone acetyltransferase ([35,53,83] and our unpublished ob-
servations). Not1 and Not5 also impact on the association of TFIID and
SAGA with promoters [57,59,60,83]. Finally efﬁcient transcription elon-
gation requires the Ccr4-Not complex [84,85], probably because the com-
plex helps RNA polymerase II to backtrack [86]. As can be seen by this
enumeration, these studies have connected more particularly the Not
subunits to transcription regulation, although the cross-linking of Ccr4
and Caf1 to transcribing ORFs suggests that as for mRNA degradation,
even though the Not subunits may participate more directly to the tran-
scription process, they are associated with the other subunits, at least in
part, for this function. Hence, association of the Not subunits in the
Ccr4-Not complex during transcriptional regulation is likely to play
some role, possibly an essential one.
2.4.3. Role in protein synthesis and degradation
Protein synthesis and degradation are strongly regulated in the cell
by a mechanism called protein quality control that includes numerous
chaperones and the proteasome [87,88]. A role of the Ccr4-Not complex,
particularly the Not subunits, in protein quality control is suggested by
the presence of the Ccr4-Not complex at translating ribosomes, the im-
portance of Not2, Not4 and Not5 for a normal level of polysomes, and
the accumulation of aggregated proteins in their absence [19]. Not4
ubiquitinates a small ribosomal protein Rps7A [19], and both subunits
of a ribosome-associated chaperone called nascent polypeptide-
associated complex, NAC [17]. This chaperone provides translation
ﬁdelity through the folding of newly synthesized proteins and pro-
tects them from interaction with inappropriate targets [89,90]. Its
mono-ubiquitination by Not4 promotes its association with the ri-
bosome and with the proteasome [20]. Hence, we have proposed
that the Ccr4-Not complex, through its Not4 subunit, is involved in
co-translational quality control of newly synthesized peptides (Collart
2012, in press). In addition, a direct effect of Not4 in substrate poly-
ubiquitination and subsequent degradation was revealed by the identi-
ﬁcation of several targets for Not4 [48–50].
Subunits of the Ccr4-Not complex are also important for assembly of
the proteasome [18]. This has been particularly well studied for the Not4
subunit, and the available evidence is that Not4 contributes to assembly
of the proteasome through interaction with proteasome subunits and
proteasome chaperones, such as Ecm29. A recent study reporting wide-
spread co-translational assembly of protein complexes [91] determined
that proteasome subunits of the regulatory particle interacted with
mRNAs encoding other regulatory subunits and Ecm29, in a manner
dependent upon intact polysomes [91]. This suggests that Ecm29
might interact with proteasome subunits co-translationally to sup-
port functional proteasome assembly. Hence, Not4 would partici-
pate in this process. Alternatively, Not4 might help assembly of the
proteasome at the ribosome. Besides Not4, other subunits of the
Ccr4-Not complex are important for integrity of the proteasome,
and, in fact, Not2 and Not5 are even more essential for this than
Not4 (unpublished observations). We believe that the role of Not4
is mostly regulatory while that of the Not2–3/5 module might be
more fundamental. This is consistent with a more pronounced growth
defect in yeast lacking Not2 or Not5 than in yeast lacking Not4. In fact,
a very important and central role for theNot2–3/5 of the Ccr4-Not com-
plex appears quite clearly from studies in higher eukaryotes, as will be
outlined below.3. The CNot3 funcional module is essential for diverse cellular
functions
The Ccr4-Not complex is essential in yeast, but each subunit is dis-
pensable for viability to various extents, except the Not1 scaffold,
which is absolutely essential. In the nematode Caenorhabditis elegans,
deletion of all Not-orthologs tested gives rise to an early embryonic le-
thal phenotype [92,93]. This has indicated that the Not subunits of the
Ccr4-Not complex are likely to be essential for embryonic development
in higher eukaryotes. In contrast the deadenylase subunits, which have
generally been expanded in eukaryotes other than S. cerevisiae, can be
inactivated without leading to embryonic lethality. In worms, that of
Caf1 but not of Ccr4 is embryonic lethal [92].
Similarly, in mouse the knockout of the CNot7 deadenylase (a Caf1
ortholog) leads to adult mice, with no overt problem except that they
have a high bone mass phenotype [94] and the males are defective in
spermatogenesis [95–97]. This speciﬁc phenotype is intriguing consid-
ering that in the adult mouse, CNot7 is one of the Ccr4-Not subunits
that is ubiquitously expressed [98]. This is not the case for all subunits
of the complex, and in particular not for CNot2 and CNot3 [98]. This
has led to the idea that different forms of the Ccr4-Not complex function
at different times and tissues and that the CNot2–CNot3 module might
functionally regulate the Ccr4-Not complex.
Like worms, mice lacking CNot3 die early in embryogenesis [99].
Blastocysts can develop and have a normal appearance. They also
occur at Mendelian frequencies and express key markers of early em-
bryonic differentiation at normal levels. However, while in epiblast
cultures trophoblast cells from not3−/− spread and support out-
growths of the inner cell mass (ICM), the ICM cells themselves exhibit
a severe outgrowth defect [99].
The importance of the Not subunits for embryonic development has
hindered the generation of knockout animals to characterize their pre-
dominant role in the adult animal. However it is interesting to note
that in humans, CNot3 was identiﬁed as a modiﬁer of mutations in
PRPF31 leading to retinitis pigmentosa with incomplete penetrance. In
asymptomatic carriers CNot3 is expressed at low levels allowing higher
expression of Prpf31 from the wild-type allele, and hence preventing
retinal degeneration [67]. CNot3 is probably a direct negative regulator
of PRPF31, since it associates with the PRPF31 promoter and its expres-
sion inversely correlates with that of PRPF31.
CNot1, CNot2, and all of the deadenylase subunits affect cell prolif-
eration and/or cell death [78,100–103], but expression of the different
subunits of the Ccr4-Not complex does not change during the cell
cycle. However CNot3, speciﬁcally, is modiﬁed at around mitosis. Its
depletion promotes mitotic arrest, most likely by increasing stability
of the mRNA encoding Mad1, a regulator of the spindle assembly
checkpoint [68].
These different studies underlie the importance of CNot3 for vari-
ous cellular functions. This critical role of the CNot3 module of the
Ccr4-Not complex has been reinforced by global studies in cell lines
or embryonic stem cells (ES cells), or ﬁnally analyses in heterozygous
knockout mice, as will be outlined below.3.1. CNot3 as a module for cellular self-renewal
CNOT3was identiﬁed in a genome-wide RNAi screen conducted in
mouse ES cells to identify genes important for cells to self-renew [71].
It was the only gene encoding a Ccr4-Not subunit that came out of the
screen. However, when all subunits of the Ccr4-Not complex were
speciﬁcally tested, it could be shown that silencing of CNot1, CNot2
and CNot3, but not of the other components of the complex, had
the same phenotype [66]. Consistently, the expression of these 3 sub-
units of the Ccr4-Not complex speciﬁcally, is high in the oocyte, fer-
tilized egg and ES cells, but becomes signiﬁcantly reduced upon
differentiation of the pluripotent ES cells.
747M.A. Collart et al. / Cellular Signalling 25 (2013) 743–751The knockdown of CNot2 and CNot3 causes an increase in differ-
entiated cells, mostly of the trophectoderm lineage. The morpholog-
ical changes induced by silencing CNot1 are somewhat different
from those caused by silencing of CNot2 and CNot3. Nevertheless in
all cases the gene expression signatures are similar to those found
during trophectoderm differentiation [66]. For the CNot3 knockdown,
this was studied in detail [71] and it correlates with a transcriptional
up-regulation of differentiation factors. It also correlateswith a reduction
of the pluripotency transcription factors Nanog, Sox2 and Oct4, which
comprise the core transcription network that controls self-renewal of
ES cells [104]. Reduction of CNot3 has no impact on the signaling path-
ways that are important for self-renewal or on the signaling pathways
that can induce differentiation. It reduces ES cell proliferation and viabil-
ity evenwhen the ES cells are insulated fromextrinsic differentiation sig-
naling or when repression of pluripotent genes is inhibited. Hence,
CNot3 regulates self-renewal independently of these signaling pathways
and is more likely to play a role in the core self-renewal circuitry.
The evidence is that CNot3 sustains self-renewal through speciﬁc reg-
ulation of genes involved in cell cycle progression and survival by being
recruited to relevant genes [71]. Indeed a large number of promoter sites,
close to transcription start sites, are bound by CNot3 inmouse ES cells. In
many cases, these promoters are co-occupied by another factor impor-
tant for self-renewal, Trim28 [105], and the sequences bound by the 2
proteins lie in close proximity and are enriched in speciﬁc chromatin
marks (histone H3 lysine 4 and lysine 27 tri-methylation). They cluster
with promoters bound by 2 other pluripotency transcription factors,
c-Myc and Zfx, but are distinct from those of the core transcription net-
work. The binding sites for the 4 factors lie in close proximity suggesting
that they might act in a cooperative manner. They mostly deﬁne genes
encoding transcription regulators involved in cell cycle and cell survival
that are down-regulated during the 14 days of embryonic body forma-
tion. The knockdown of CNot1, CNot2 and CNot3 also increases the dif-
ferentiation of human ES cells [66]. Hence, the role of these Not proteins
in maintenance of self-renewal of ES cells is conserved.
The enrichment for cancer genes supports the idea that the regulato-
ry networks active in self-renewal in stem cells may be active in certain
cancers. This idea led us to investigate a possible role of CNot3 in devel-
opment of cancers. CNOT3 is indeed mutated in human cancers [106].
Furthermore, the pattern of mutations in CNOT3may suggest its poten-
tial implication in tumorigenesis. Indeed 27mutations in the coding se-
quence of CNot3 (which is 754 amino acids long) are found in the eight
different types of cancers reported in the COSMIC databasev62 [106].
Strikingly, 9 mutations in CNot3 (33%) are recurrent with 6 mutations
causing a glutamic acid (E) to lysine (K) amino acid change at position
20, and 3 mutations at position 70. This distribution of mutations is un-
likely to be observed by chance (p value of 1.2×10−16, binomial test). 6
out of 9 recurrent mutations are speciﬁc to prostate cancer, 2 to hema-
topoietic and lymphoid tissues and 1 to the urinary tract. Both recur-
rently mutated amino acids (E20 and E70) are located in the Not3
N-terminal domain (see Fig. 1), which is extremely conserved downH.sapiens
P.troglodytes
R.macaque
M.musculus
B.taurus
L.africana
M.eugenii
O.anatinus
A.carolinensis
X.tropicalis
D.rerio
P.marinus
S.cerevisiae_CNot5
S.cerevisiae_CNot3
E20K                                              
Fig. 3. Amino acid alignment of the N-terminus of vertebrate CNot3 protein and S. cerevisiae
tated in cancers. Dots denote amino acids identical to human. Dashes denote missing data.to yeast (Fig. 3). Moreover glutamic acid at position 20 of human
CNot3 remains unchanged in vertebrates and in yeasts (in Not3 and
Not5). Glutamic acid at position 70 is conserved in Gnathostomata and
is orthologous to aspartic acid found in lampreys and yeasts (again in
Not3 and Not5). Similarity of negatively charged glutamic and aspartic
acids additionally emphasizes the strength of evolutionary constraints
over this residue in CNot3. On the other hand, in cancers negatively
charged glutamic acids at positions 20 and 70 are mutated to positively
charged lysines, which potentially may cause substantial conformational
changes in the CNot3 protein.
Recurrence of mutations at the same sites of the protein together
with their heterozygous status is consistent with a “gain of function”
type of mutations in cancers. This is also in line with frequent ampli-
ﬁcations of the CNot3 locus in prostate and ovarian cancer cell lines
(from the canSAR database: https://cansar.icr.ac.uk/cansar/). These
data on the putative activating somatic alterations of CNot3 in cancer
are complementary to the CNot3 loss of function phenotypes in Dro-
sophila and mouse ([71] and see below). Both types of data point to
the function of CNot3 in cell self-renewal and in the control of cell
differentiation.
3.2. CNot3 in heart function
A global RNA interference silencing screen of genes conserved
between mammals and Drosophila melanogaster determined that
the knockdown of several Ccr4-Not subunits, in particular CNot1,
CNot3, CNot4 and to a lesser extent CNot2, reduces expression of a
reporter construct speciﬁcally expressed in cardioblasts [99]. The
strongest phenotypewas found for CNot3,whose cardiac-speciﬁc knock-
down resulted in dilated cardiomyopathy in Drosophila. Nevertheless
similar abnormal heart structure and severely impaired cardiac function
was observed in the CNot1 speciﬁc knockdown, as well as in the knock-
downof Ubc4, an E2 enzyme known to functionwith the CNot4 E3 ligase
[107].
The importance of CNot3 for heart function in the adult animal was
evaluated in heterozygous CNot3 null mice. Thesemice express half the
amount of CNot3, but normal amounts of the other subunits of the
Ccr4-Not complex [70]. The haploinsufﬁciency showed no overt struc-
tural changes in the heart, but cardiac contractility was reduced, and
this was due to an intrinsic impairment in heart function. Cardiac stress
leads to exaggerated heart failure in not3 heterozygous mice, and ex-
pression of genes important for heart function was reduced. Whole
hearts from the heterozygous mice bear reductions in speciﬁc chroma-
tin marks (histone 3 lysine 4 tri-methylation and lysine 9 acetylation)
that can be restored by treatment of hearts with a histone deacetylase
inhibitor (valproic acid, VPA). Heart function, and all of these pheno-
types, can be rescued by VPA. Thus, genes important for heart function
might be under the control of the acetylation and methylation states of
histone H3, themselves dependent upon the Ccr4-Not complex, in par-
ticular upon CNot3. These ﬁndings are consistent with studies in yeast,                                                 E70K 
Not3 and Not5 proteins. Red boxes correspond to amino acid positions recurrently mu-
S. cerevisiae is represented by the two paralogous proteins, Not3 and Not5.
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methylation of histone H3 lysine 4 [109,110] are reduced in cells
lacking Not4, and particularly Not5. They suggest that these sub-
units of the Ccr4-Not complex impact on chromatin marks, which
in turn lead to alterations in gene expression through epigenetic
reprogramming.
An important role in heart function for the Ccr4-Not complex would
be supported by the ﬁnding ofmutations in the Ccr4-Not genes that cor-
relate with heart disease. Indeed, in humans, the CNot1 locus was one of
the 12 loci correlated with different cardiac defects in genome-wide as-
sociation studies performed by 2 consortia using very stringent signiﬁ-
cance thresholds. Speciﬁc analysis of CNot3 revealed that there is a
signiﬁcant correlation between a common minor allele of CNot3 with a
modiﬁcation about 969 base pairs upstream of the transcription start
site and an abnormal cardiac repolarization [99].
3.3. CNot3 as sensor for nutrient availability
Not3 heterozygous mice are born smaller than wild-type mice, and
remain smaller throughout life [70]. All organs have a normal histology,
but are smaller than organs in the wild-type mice, though at a similar
ratio to body weight. The exceptions are liver and adipose tissue, which
are particularly reduced. Hepatic lipids accumulate poorly and adipocytes
inwhite and brown adipose tissues are smaller.Metabolic rate of the het-
erozygous animals is increased, and glucose and triglyceride blood levels
are reduced under fasting and after feeding. Since insulin levels are nor-
mal, this means that the insulin sensitivity is increased, and this even
on a high fat diet, or in genetically obese mice. In the liver of 12-week
old heterozygous mice, only about 1% of the mRNAs are expressed with
a more than 2-fold difference in heterozygous knockout mice compared
to wild-type mice. Most of these mRNAs are involved in metabolic pro-
cesses, in particular in lipid metabolism, with catabolism-related genes
up-regulated and lipogenic genes down-regulated. For somemRNAs test-
ed, up-regulation correlated with an increased length of their poly(A)
tails, and the 3′UTR regions of these genes were necessary and sufﬁcient
to mediate the down-regulation of reporter constructs by CNot3. The ev-
idence is that CNot3 mediates association of the deadenylase with the
mRNA via this 3′UTR [70].
The level of CNot3 in the liver and adipose tissue consistently de-
creases after 24 h of fasting, and returns to control levels upon refeeding.
Since CNot3 mRNA levels do not change, the regulation of CNot3 is
post-transcriptional. In this context, it is interesting to note that the 2
orthologs of CNot3 in yeast, Not3 and Not5, have also been reported to
decrease in response to nutrient limitation, and this occurs by a post-
transcriptional mechanism [60]. The yeast orthologs become progres-
sively hyperphosphorlyated and less abundant when yeast cells grow
from high glucose to glucose depletion and then cease completely to
grow because of nutrient depletion. Furthermore, in yeast cells the ab-
sence of Not5 also leads to signiﬁcant changes in expression ofmetabolic
genes [111]. These observations are consistent with a conserved re-
sponse of Not3/5 to nutrient levels for regulation of metabolic genes.
4. CNot3 marks mRNAs at birth, for regulation from synthesis to
translation and degradation
CNot3 is essential for embryonic development. Consistently, CNot3
is important for maintenance of ES cell renewal. However, CNot3 also
appears to be essential for tissue-speciﬁc functions in the fully devel-
oped animal. It is essential at least for cardiac and liver function, in
this latter case in particular for lipidmetabolism. Several interesting ob-
servations emerge from these different studies.
First, the function for CNot3 deﬁned in a given “system” is related to
the expression program that is “on” in this system: in ES cells, the pro-
gram for self-renewal, in cardiac cells, cardiac speciﬁc gene expression,
and in liver cells, genes related to lipid metabolism for which this organ
is specialized. In yeast, global analyses of gene expression under differentgrowth conditions have already revealed that the genes, which require
the Ccr4-Not complex for appropriate expression, are different in differ-
ent growth conditions [111]. Hence, the speciﬁcity of Ccr4-Not function
at a given time in a speciﬁc cell is deﬁned by the genetic program,which
is on.
Second, gene regulators acting at different levels seem to be able to
mobilize CNot3. In the case of self-renewal of ES cells, CNot3 is reported
to associatewithDNAand coincide at loci that are bound by speciﬁc tran-
scriptional regulators [71]. Hence, speciﬁc transcription factors at pro-
moters may contribute to recruit CNot3 to DNA, and the targets of
CNot3 appear to be deﬁned at the transcription level. This is consistent
with previous studies, which have reported association of Not2, Not3 or
Not5 with transcribing ORFs [57,80–82]. In the case of the role of CNot3
in expression of cardiac genes [99], the phenotypes associated with a re-
duction of CNot3 correlate with speciﬁc chromatin marks. This tells us
that the chromatin marks are directly connected to the impact of
CNot3 on gene expression, be it transcriptional or post-transcriptional
(since results are emerging to show that chromatin marks are also relat-
ed to post-transcriptional gene regulation [112]). How the chromatin
marks are “set” by CNot3 is not determined, but one can hypothesize
that the initial event is also a speciﬁc recruitment of CNot3 by cardiac-
speciﬁc transcription factors to genes expressed in the heart. In any
event, this conﬁrms that CNot3 targets are deﬁned already in the
nucleus.
In contrast, in liver cells CNot3 is reported to recruit the deadenylase
module of the Ccr4-Not complex to the 3′UTR of mRNAs [70]. CNot3-
dependent regulation of a reporter construct with a heterologous pro-
moter suggests that the 3′UTR is sufﬁcient for this regulation by CNot3
in liver cells. This would suggest that CNot3 action on this set of genes
in the liver is uncoupled to their promoters. However, it is unclearwheth-
er one can conclude from a reporter construct transfected into cell lines
for which the 3′UTR is sufﬁcient for CNot3 regulation, that coordinate
regulation of metabolic genes by CNot3 is really only strictly dependent
upon the 3′UTR of their mRNAs. It could still be that at the level of a
liver cell the speciﬁcity of CNot3 function formetabolic genes ﬁnds its or-
igin at the recruitment of CNot3 to relevant genes by tissue-speciﬁc tran-
scription factors. Deﬁning exactly to which extent functional cross-talk
between promoter and 3′UTR is relevant to coordinate gene regulation
is certainly a challenge in such complex systems.
To summarize, from these studies it appears that CNot3, and the
Ccr4-Not complex, acts downstream ofmany different speciﬁc gene reg-
ulators. What then is the speciﬁcity of the regulation by the Ccr4-Not
complex? Combining what we have learned from higher eukaryotes
with what we know about the different functions of the Ccr4-Not com-
plex in particular in yeast, we can suggest that the complex contributes
to integrate the regulation of gene expression at all levels (Fig. 4). The
presence of Not3/Not5 at active genes makes it possible to recruit Not4
(via the Not1 scaffold) to ubiquitinate and regulate levels of chromatin
modiﬁers and transcription factors at these genes (Fig. 4). The outcome
of this could be positive or negative regulation of transcription, consis-
tently with the observation that CNot3 appears as a positive regulator
in cardioblasts, but as a negative regulator in ES cells. Once mRNA syn-
thesis is completed, Not3/5 (and/or other subunits of the Ccr4-Not com-
plex) might be transferred from promoters to mRNAs. This will provide
mRNAs with “marks” originating from the nucleus, which will follow
them into the cytoplasm and also provide Ccr4-Not-dependent regula-
tion of gene expression in the cytoplasm. Consistently, the Ccr4-Not
complex is present in translating ribosomes [19], where it can then im-
pact on translation and protein quality control. Here again, Not4 is likely
to play an important regulatory role, by ubiquitinating proteins such as
NAC and Rps7A. In polysomes the Ccr4-Not complex can also contribute
to translation arrest and/or mRNA degradation if translation is arrested
or encounters problems. Indeed, recent evidence has shown that Not4
contributes to co-translational quality control and that at least part of
this effect is probably via mRNA degradation ([19,113,114] and for re-
view see Collart 2012, in press) (Fig. 4).
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tegrated function for the yeast Ccr4-Not complex, whereby the Not2–3/
5 module in particular may act early on in the nucleus to target the
Ccr4-Not complex to speciﬁc loci, probably marked by speciﬁc tran-
scription factors. By being present at promoters, Not2–3/5 is then able
to recruit the Ccr4-Not complex, including the Not4 E3 ligase. In turn,
Not4 has the ability to ubiquitinate transcription factors or factors that
act on chromatin modiﬁcations to module the transcription status of
these loci (Fig. 4). Obviously, while we propose here a predominant
role for Not2–3/5 for initial recruitment to promoters, it could be that
other subunits of the Ccr4-Not complex have this role in some condi-
tions. This is compatiblewith the observation that there are indeed pro-
moters towhich other subunits of the Ccr4-Not complex predominantly
cross-link [81]. Once recruited, the Ccr4-Not complex can participate in
productive elongation during the transcription elongation process [86].
In case of abortive transcription, the Ccr4-Not can contribute to nuclear
RNA surveillance, consistently with its described putative role in this
process [63–65]. When the mRNAs produced at these loci are complet-
ed, one or more modules of the Ccr4-Not complex might be transferred
from the promoter to the mRNA. This could occur prior to, or after, the
association of speciﬁc RNA binding proteins to themRNA 3′UTRs. Final-
ly, themarkedmRNAswill be exported to the cytoplasm for translation
by the ribosome. We ﬁnd the Ccr4-Not complex at translating ribo-
somes [19], maybe at the ribosomes translating the mRNAs, which
were “marked” via Not2–Not3/5 in the nucleus. The mRNAs marked
this way may need to be coordinately degraded or stored in response
to extracellular signals, or might encode subunits of the same complex,
and the Ccr4-Not complexwould play an essential role in this coordina-
tion. It has long been known that perfect complementation of the
knockout of endogenous genes often requires the endogenous promot-
er and 3′UTR, and our model for Ccr4-Not function would account for
this long-standing observation. Obviously we are still far from havingPol I
TF
Pol II
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Not3/5 
AAAAA 
AAA 
Caf1/Ccr4 
A A 
NUCLE
CYTOPL
Not4 
Not3/5 
Not1 Not3/5 
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Fig. 4. Model for the implication of the different modules of the yeast Ccr4-Not complex in
1. In the nucleus the Not2–Not3/5 module is associated with loci marked by speciﬁc transc
Not4, to the loci.
2. By being recruited, the Not4 E3 ligase has the ability to ubiquitinate transcription factor
3. When the mRNAs produced at these loci are completed, the Not2–Not3/5 module might
to interact with 3′UTRs independently of the promoter.
4. The “marked” mRNAs will be exported to the cytoplasm for translation by the ribosom
5. The Ccr4-Not complex is present in translating ribosomes, probably those translating th
6. Not4 contributes to co-translational protein quality control and might recruit the prote
7. The Caf1/Ccr4 module deadenylates mRNA after translation arrest or termination.the data that can fully establish this model, but it is amodel that can ex-
plain and integrate a great number of observations made so far, and
which will be exciting to explore in the future.
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